NCT01164826View on ClinicalTrials.gov

Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Healthy
Interventions
DRUG

Nabumetone

Nabumetone 750 mg Tablets of Dr. Reddy's Laboratories Limited

DRUG

Relafen

Relafen® 750 mg Tablets of Glaxosmithkline Research Triangle Park, NC.

Trial Locations (1)

500037

Bioserve Clinical Research Pvt. Ltd., Hyderabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY